 |
|
Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
June 08, 2007Endemic Burkitt lymphoma is a form of cancer that accounts for up to 74% of malignant disorders in children in equatorial Africa. Malaria and Epstein-Barr virus (EBV) are known cofactors in its development, but to date, their relative contribution has not been well understood. In a new study published online in the open-access journal PLoS Pathogens, researchers at the Karolinska Institutet in Stockholm explain how certain Plasmodium falciparum antigens directly induce Epstein-Barr virus (EBV) reactivation, increasing the risk of Burkitt lymphoma.
EBV is a ubiquitous virus that establishes a lifelong persistence following primary infection. How EBV affects its host hinges on a balance between viral latency, viral replication, and host immune responses. Generally harmless in almost every host and rarely a cause of disease, reactivation of EBV has been causally associated with various cancers. Acute malaria infection is known to increase the level of circulating EBV, but the precise mechanisms through which this virus reactivation occurs had been previously unknown.
Now, Arnaud Chene and colleagues have identified CIDRla as the first microbial protein able to spur a latently EBV-infected cell into active production. Their results suggest that P. falciparum-derived proteins can lead to a direct reactivation of EBV during acute malaria infection, increasing the risk of Burkitt lymphoma development for children living in malaria-endemic areas.
Public Library of Science
Public Library of Science
Pediatric Cancer News and Current Pediatric Cancer Events RSSNovel anticancer strategy moves from laboratory to clinic
Researchers at Emory University have developed a novel anti-tumor compound that represents a distinct strategy: targeting one of the most important "intercept points" for cancer cells.
Study examines genetic defects linked to body abnormalities in patients with childhood cancer
Children with cancer have a higher prevalence of body abnormalities, such as asymmetric lower limbs and curvature of the spine, suggesting that the genetic defect responsible for the abnormality may play a role in the development of cancer, according to a study in the January 2 issue of JAMA.
A search for protection against chemotherapy cardiotoxicity
Researchers at the University of Grenoble, in France, have discovered that erythropoietin administration prevents acute cardiotoxic effects induced by doxorubicin and trastuzumab exposures.
Gene identified for Crohn's disease in children
Pediatrics researchers have identified a gene variant that raises a child's risk of Crohn's disease, a chronic and painful condition attributed to inflammation of the gastrointestinal tract.
Gene discovered for type 1 diabetes in children
Pediatrics researchers at The Children's Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child's risk for type 1 diabetes, formerly called juvenile diabetes.
Researchers find that childhood sarcoma increases risk of blood clots
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have determined that children and young adults with a form of cancer called sarcoma are at increased risk of having a thromboembolic event (TE) in their veins.
Teens overlooked in cancer research
McMaster University pediatric cancer specialist Dr. Ronald Barr says the teen gap in cancer care has been overlooked for far too long.
Breaking the medical image communication barrier
Using a new grid computing system, radiologists, physicians and pediatric oncologists at 40 hospitals all over North America are now quickly and securely exchanging high-resolution medical images.
Longer anthracycline therapy reduces heart failure in adult cancer patients
Stretching out a dose of chemotherapy over six or more hours may reduce the risk of heart problems caused by certain commonly used cancer drugs.
Prenatal vitamins may reduce risk of brain tumors in children
Women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
More Pediatric Cancer News Articles
| © 2008 BrightSurf.com |